Consensus estimates project CLB earnings at $0.09 per share and revenue of $125.1M, down 3.9% year-over-year.
Core Laboratories will report Q2 2026 earnings on July 29 after the market closes. Analysts expect earnings of $0.09 per share and revenue of $125.1M, reflecting a 3.9% decline from the same period last year.
The company has consistently beaten earnings estimates over the past two years, though revenue growth has remained subdued amid industry challenges. Comparable quarterly results from prior periods show modest fluctuations in profitability metrics.
Market participants will focus on guidance and operational updates to assess near-term performance trends.